NCT02226926View on ClinicalTrials.gov

Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

September 30, 2000

Conditions
Healthy
Interventions
DRUG

Aggrenox

DRUG

Persantin Retard

DRUG

Acetylsalicylic acid

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02226926 - Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers | Biotech Hunter | Biotech Hunter